ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of COPD.
Pre-bronchodilator FEV1 less than or equal to 70.0% and greater than or equal to 0.70L
Ex-Smokers with at least a 10 pack-year history.
You may not be if
Current of secondary diagnosis of asthma or current diagnosis of atopy.
Other respiratory disorders other than COPD.
Other inflammatory diseases.
Abnormal and clinically significant chest x-ray or ECG.
Lung resection surgery within past 1 year.
History of cancer not in remission within past 2 years.
Serious, uncontrolled disease.
Pregnancy or planning to become pregnant during the study.
Clareo Health | ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.
